Trials / Completed
CompletedNCT00671749
Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris
A Clinical Assessment of Combination Therapy With Differin® Gel, 0.3% With Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 12 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
This study is to determine the efficacy and safety of 12 week treatment with Differin® Gel 0.3% applied in the evening, in combination with Duac® (Clindamycin/Benzoyl Peroxide Gel) applied in the morning, in Subjects with Acne vulgaris.
Detailed description
Same as above.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | adapalene gel, 0.3% | Applied once daily at bedtime |
| DRUG | clindamycin/benzoyl peroxide gel | Applied once daily in the morning |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2008-08-01
- Completion
- 2008-08-01
- First posted
- 2008-05-05
- Last updated
- 2022-08-23
- Results posted
- 2016-03-16
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00671749. Inclusion in this directory is not an endorsement.